Literature DB >> 15063361

Cytokine imbalance in acute coronary syndrome.

Samir E Alam1, Samer S Nasser, Khaled E Fernainy, Aida A Habib, Kamal F Badr.   

Abstract

The excessive mortality of coronary heart disease is attributed primarily to rupture and thrombotic transformation of the atherosclerotic plaque. Inflammation plays a critical role in plaque destabilization and vulnerability. Inflammation is not confined to the culprit segment but is convincingly widespread in the coronary and remote vascular beds. Systemic inflammatory, thrombotic and hemodynamic factors are relevant to the pathological and clinical outcome. In addition to their fundamental role in thrombosis, there is ample evidence that platelets contribute significantly to promoting plaque inflammation. A new paradigm of unbalanced cytokine-mediated inflammation is emerging, providing diagnostic and therapeutic opportunity for intervention. Amplifying intrinsic anti-inflammatory mechanisms constitutes attractive avenues for future investigation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15063361     DOI: 10.1016/j.coph.2003.10.011

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  11 in total

1.  Effects of simvastatin within two weeks on anti-inflammatory cytokine interleukin 10 in patients with unstable angina.

Authors:  J-J Li; Y-S Li; C-H Fang; R-T Hui; Y-J Yang; J-L Cheng; R-L Gao
Journal:  Heart       Date:  2005-08-05       Impact factor: 5.994

2.  Temporal changes in biomarkers and their relationships to reperfusion and to clinical outcomes among patients with ST segment elevation myocardial infarction.

Authors:  Sean van Diepen; Wendimagegn G Alemayehu; Yinggan Zheng; Pierre Theroux; L Kristin Newby; Kenneth W Mahaffey; Christopher B Granger; Paul W Armstrong
Journal:  J Thromb Thrombolysis       Date:  2016-10       Impact factor: 2.300

3.  Anti-inflammatory action of diltiazem in patients with unstable angina.

Authors:  L Dubey; Z Hesong
Journal:  Postgrad Med J       Date:  2006-09       Impact factor: 2.401

4.  Correlation between interleukin 6 and interleukin 10 in acute myocardial infarction.

Authors:  Larisa Dizdarević-Hudić; Zumreta Kusljugić; Fahir Baraković; Selmira Brkić; Damir Sabitović; Elmir Jahić; Maida Isabegović; Elnur Smajić; Igor Hudić; Katarina Divković
Journal:  Bosn J Basic Med Sci       Date:  2009-11       Impact factor: 3.363

5.  Relation between proinflammatory to anti-inflammatory cytokine ratios and long-term prognosis in patients with non-ST elevation acute coronary syndrome.

Authors:  T Kilic; D Ural; E Ural; Z Yumuk; A Agacdiken; T Sahin; G Kahraman; G Kozdag; A Vural; B Komsuoglu
Journal:  Heart       Date:  2006-03-17       Impact factor: 5.994

6.  Effects of bioactive ceramics on the pathogenesis of rat vascular smooth muscle cells treated with phorbol 12-myristate 13-acetate.

Authors:  Tae-Sung Lee; Kwan-Kyu Park; Hae-Sim Cho; Young-Ae Choo; Meeyul Hwang
Journal:  J Mater Sci Mater Med       Date:  2007-10-04       Impact factor: 3.896

7.  Lack of an Association between the SDF-1 rs1801157 Polymorphism and Coronary Heart Disease: A Meta-Analysis.

Authors:  Nan Wu; Xiaowen Zhang; Pengyu Jia; Dalin Jia
Journal:  Sci Rep       Date:  2015-07-02       Impact factor: 4.379

8.  Chemerin is a novel biomarker of acute coronary syndrome but not of stable angina pectoris.

Authors:  Qingwei Ji; Yingzhong Lin; Zhishan Liang; Kunwu Yu; Yuyang Liu; Zhe Fang; Ling Liu; Ying Shi; Qiutang Zeng; Chao Chang; Meng Chai; Yujie Zhou
Journal:  Cardiovasc Diabetol       Date:  2014-11-01       Impact factor: 9.951

9.  Plasma Chemerin Levels Are Increased in ST Elevation Myocardial Infarction Patients with High Thrombus Burden.

Authors:  Ahmet Hakan Ateş; Uğur Arslan; Aytekin Aksakal; Ahmet Yanık; Metin Özdemir; Selim Kul
Journal:  Cardiol Res Pract       Date:  2018-03-26       Impact factor: 1.866

10.  Decreased plasma IL-35 levels are related to the left ventricular ejection fraction in coronary artery diseases.

Authors:  Yingzhong Lin; Ying Huang; Zhengde Lu; Cheng Luo; Ying shi; Qiutang Zeng; Yifeng Cao; Lin Liu; Xiaoyan Wang; Qingwei Ji
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.